Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis.

Autor: Katarina Mirković, Carolina R C Doorenbos, Wendy A Dam, Hiddo J Lambers Heerspink, Maartje C J Slagman, Ferdau L Nauta, Andrea B Kramer, Ronald T Gansevoort, Jacob van den Born, Gerjan Navis, Martin H de Borst

Publikováno v: PLoS ONE, Vol 8, Iss 2, p e55887 (2013)

Non-invasive tubulointerstitial damage markers may allow better titration and monitoring of renoprotective therapy. We investigated the value of urinary vitamin D binding protein excretion (uVDBP) as a tubulointerstitial inflammation and fibrosis mar

Externí odkaz: https://doaj.org/article/68c6f354370246a4b0432d0b83941842

Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease

Autor: Gerjan Navis, Carolina R. C. Doorenbos, Martin H. de Borst, Reinold O. B. Gans, Ido P. Kema, Liffert Vogt, Milton M. de Cuba, Jacob van den Born

Publikováno v: Journal of steroid biochemistry and molecular biology, 128(1-2), 56-61. Elsevier Limited
Journal of steroid biochemistry and molecular biology, 128(1-2), 56-61. PERGAMON-ELSEVIER SCIENCE LTD

Vitamin D deficiency is common in chronic kidney disease (CKD). Increased urinary loss of vitamin D binding protein (VDBP), the main transporter of 25-hydroxyvitamin D-3 in the circulation, has been postulated to contribute to vitamin D deficiency in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476b5f733b31fabaa92c7d0bd39ad5ea
https://pure.amc.nl/en/publications/antiproteinuric-treatment-reduces-urinary-loss-of-vitamin-dbinding-protein-but-does-not-affect-vitamin-d-status-in-patients-with-chronic-kidney-disease(c933e02c-7a14-4f88-9701-70f10e73d939).html